Insight 2811, Inc. Danaher Corp Transaction History

Insight 2811, Inc.

$200 Million
Q1 2024

A detailed history of Insight 2811, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Insight 2811, Inc. holds 2,027 shares of DHR stock, worth $487,311. This represents 0.25% of its overall portfolio holdings.

Number of Shares

2,027

Previous 2,227 8.98%

Holding current value

$487,311

Previous $515,000 1.75%

% of portfolio

0.25%

Previous 0.27%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$224.58 - $256.19 $44,916 - $51,238	-200 Reduced 8.98%	2,027 $506,000
Q4 2023 Feb 12, 2024	SELL	$185.1 - $233.13 $2,406 - $3,030	-13 Reduced 0.58%	2,227 $515,000
Q3 2023 Nov 14, 2023	BUY	$233.08 - $265.59 $5,127 - $5,842	22 Added 0.99%	2,240 $555,000
Q2 2023 Aug 04, 2023	SELL	$224.99 - $256.14 $125,094 - $142,413	-556 Reduced 20.04%	2,218 $532,000
Q1 2023 May 11, 2023	SELL	$239.75 - $277.0 $122,512 - $141,547	-511 Reduced 15.56%	2,774 $699,000

Q4 2022 Feb 07, 2023	BUY	$241.42 - $282.29 $4,586 - $5,363	19 Added 0.58%	3,285 $872,000
Q3 2022 Nov 14, 2022	BUY	$247.06 - $1507.4 $593,191 - $3.62 Million	2,401 Added 277.57%	3,266 $844,000
Q2 2022 Aug 09, 2022	BUY	$237.11 - $299.66 $10,432 - $13,185	44 Added 5.36%	865 $219,000
Q1 2022 May 06, 2022	SELL	$257.27 - $315.76 $5,402 - $6,630	-21 Reduced 2.49%	821 $241,000
Q4 2021 Feb 01, 2022	BUY	$292.08 - $329.01 $245,931 - $277,026	842 New	842 $277,000
Q3 2021 Nov 04, 2021	SELL	$272.21 - $332.43 $230,561 - $281,568	-847 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$225.08 - $271.69 $190,642 - $230,121	847 New	847 $227,000

Others Institutions Holding DHR

# of Institutions

2,372

Shares Held

559M

Call Options Held

3.54M

Put Options Held

3.99M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $175B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight 2811, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Insight 2811, Inc. with notifications on news.

Account